Key Points
LONDON, Nov 16 (Reuters) - The Bill & Melinda Gates Foundation has given $23.6 million to U.S.-based life science company Micron Biomedical to fund the first ever mass production of needle-free vaccine technology...
The technology works by delivering the vaccine via dissolvable microneedles attached to the skin on a patch-like device...
A trial in Gambia earlier this year showed that Microns device delivered the measles-rubella vaccine, produced by the Serum Institute of India, to adults, babies and toddlers as safely and effectively as syringes, and produced a similar immune response...
The technology "could help overcome some of the most substantial barriers to eradicating measles and rubella globally", said James Goodson, senior scientist in the immunization division at the U.S. Centers for Disease Control and Prevention (CDC), which has also partnered with Micron...
Part of the Health & Pharma team, recent notable pieces include an investigation into healthcare for young transgender people in the UK as well as stories on the rise in measles after COVID hit routine vaccination, as well as efforts to prevent the next pandemic..
You might be interested in
WHO, Gates Foundation seek to reverse falling childhood vaccination rates
25, Apr, 23The World Health Organization is working with the Bill & Melinda Gates Foundation and other not-for profit organizations and agencies to reverse a pandemic-driven decline in routine childhood vaccinations.
I Drank Water From Fecal Sludge: Weird Things that Bill Gates Did For A Cause
28, Oct, 23Bill Gates on several occasions has mentioned some of the weirdest things he has done for a cause. The billionaire philanthropist through such peculiar acts has brought sanitation issues to notice through the Bill and Melinda Gates Foundation.
Funding brings first new TB vaccine in a century a step closer
28, Jun, 23Two major players in global health philanthropy are joining forces to fund the final stage of trials for what could be the first new vaccine against tuberculosis (TB) in more than 100 years.